Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for Treatment of orf virus Infections

The aim of the research was to study a new cidofovir/sucralfate drug product to be used as a spray for treating the mucosal and/or skin lesions. The product, i.e., a water suspension of sucralfate (15% w/w) and cidofovir (1% w/w), combines the potent antiviral activity of the acyclic nucleoside phosphonate cidofovir ((S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine) and the wound healing properties of sucralfate gel (sucrose octasulphate basic aluminum salt). The product was characterized in vitro with respect to compatibility between drug and carrier, spray particle size, spray deposition, drying kinetics, and drug content and release. An interaction between the two active substances was found. The interaction between sucralfate and cidofovir was counteracted by introducing sodium dihydrogen phosphate (16% w/w) in the preparation. The spray formulation containing cidofovir/sucralfate gel painted the skin and dried quickly to a scab, remaining firmly adhered to the lesions. The therapeutic paint was tested in vivo on lambs infected with orf virus by treating the animals with different cidofovir/sucralfate formulations (0.5% or 1% cidofovir + sucralfate 15% + NaH2PO4 16% w/w) and with sucralfate gel suspension alone as control. The treatment with formulations containing cidofovir and phosphate salt for four consecutive days resulted in a rapid resolution of the lesions, with scabs containing significantly lower amounts of viable virus when compared with untreated lesions and lesions treated with sucralfate suspension alone.

[1]  I. Damon,et al.  ORF virus infection in children: clinical characteristics, transmission, diagnostic methods, and future therapeutics. , 2007, The Pediatric infectious disease journal.

[2]  P. Nettleton,et al.  Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. , 2007, Antiviral research.

[3]  A. Guercio,et al.  A real time PCR assay for the detection and quantification of orf virus. , 2006, Journal of virological methods.

[4]  E. De Clercq,et al.  Activities of Acyclic Nucleoside Phosphonates against Orf Virus in Human and Ovine Cell Monolayers and Organotypic Ovine Raft Cultures , 2005, Antimicrobial Agents and Chemotherapy.

[5]  Hassane Izzedine,et al.  Antiviral drug-induced nephrotoxicity. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  A. Zaghloul,et al.  Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice. , 2003, International journal of pharmaceutics.

[7]  E. De Clercq,et al.  Local treatment of HPV‐induced skin lesions by Cidofovir , 2002, Journal of medical virology.

[8]  A. Banati,et al.  Topical use of Sucralfate Cream in second and third degree burns. , 2001, Burns : journal of the International Society for Burn Injuries.

[9]  E. De Clercq,et al.  A case of human Orf in an immunocompromised patient treated successfully with cidofovir cream , 2001, Journal of medical virology.

[10]  A. Mercer,et al.  Parapoxviruses are strongly inhibited in vitro by cidofovir. , 2000, Antiviral research.

[11]  Zabawski Ej A review of topical and intralesional cidofovir. , 2000 .

[12]  H. Reid,et al.  Restriction endonuclease profiles of orf virus isolates from the British Isles , 1998, Veterinary Record.

[13]  H. Reid,et al.  Tissue culture-propagated orf virus vaccine protects lambs from orf virus challenge , 1996, Veterinary Record.

[14]  P. Colombo,et al.  Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases , 1993, Alimentary pharmacology & therapeutics.

[15]  Philip K. Thornton,et al.  Investing in animal health research to alleviate poverty. , 2002 .

[16]  G. Caillé,et al.  Sucralfate Drug Interaction Studies , 1995 .

[17]  G. Tytgat,et al.  Sucralfate : from basic science to the bedside , 1995 .

[18]  S. Rossi,et al.  Rheological study of sucralfate humid gel: a contribution to the comprehension of its stability properties , 1992 .

[19]  R. Nagashima,et al.  Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate. , 1980, Arzneimittel-Forschung.